论文部分内容阅读
一家领先的民营工业生物技术公司——凯赛生物产业(上海)公司专注于特种生物基化学品研发,该公司已于2016年6月22日宣布,对其生物基长链二元酸(LCDA)生产能力进行重大扩张,并建设生产设施用于生产生物戊二胺(DN5)和生物尼龙(生物-PA)。凯赛生物产业现有的生产设施在山东省金乡,拥有LCDA生产线,每年生产数千吨的DN5和生物-PA。新项目将启动LCDA和相关的长链尼龙新的投资,设在新疆省乌苏市,将提供LCDA生产的显著扩张以及额外的50万t/a 1,5-戊甲撑二胺、100万t/a尼
A leading privately held industrial biotechnology company, Cathay Bio Industries (Shanghai), specializes in the development of specialty biobased chemicals. The company announced on June 22, 2016 that its biobased long-chain dicarboxylic acid (LCDA ) Capacity expansion and build production facilities for the production of bio-pentamethylene diamine (DN5) and bio-nylon (bio-PA). The existing production facilities in Cathay Biotech have LCDA production lines in Jinxiang, Shandong Province, producing thousands of tons of DN5 and bio-PA annually. The new project will launch a new investment in LCDA and related long-chain nylon, located in Wusu, Xinjiang Province, which will provide a significant expansion of LCDA production as well as an additional 500,000 t / a 1,5- pentamethylenediamine and 1 million t / a Nepal